2022年泌尿生殖系统肿瘤研讨会(GU 2022)
肿瘤科展览会|
会议地点: 美国 旧金山/San Francisco, California, United States
会议时间: 2022年2月17-19日
行业: 肿瘤科会议
会议简介:
2022年泌尿生殖系统肿瘤研讨会(ASCO-GU2022)将于2022年2月17-19日在美国旧金山举行。
泌尿生殖系统肿瘤研讨会是一个为期三天的科学和教育会议，旨在满足医生和其他诊断、治疗和研究GU恶性肿瘤相关专业人士的需要。泌尿生殖道肿瘤研讨会由美国临床肿瘤学会（ASCO）、美国放射肿瘤学会（ASTRO）和美国泌尿肿瘤学会（SUO）共同主办。上届泌尿生殖系统肿瘤研讨会有4500名专人士与会。
美国临床肿瘤学会(ASCO)成立于1964年，是世界上最大、最具影响力的肿瘤专业学术组织，致力于癌症的预防、治疗及改善对患者的护理，ASCO是唯一涵盖所有肿瘤亚专科的组织。ASCO在全球150多个国家和地区拥有超过45000名成员，其中国际会员约占协会会员总数的三分之一，会员包括肿瘤学领域宣及其亚专科的临床肿瘤科医师、参与认可的肿瘤学训练计划的医师和医疗专家、肿瘤科护士以及肿瘤科执业医师等等。
美国放射肿瘤学会（ASTRO）成立于1958年，是世界上首屈一指的放射肿瘤学组织。ASTRO拥有超过10000名会员，包括医生、护士、生物学家、物理学家、放疗技师、剂量师和其他专业从事放谢治疗的医疗保健专业人员。 作为领先的放射肿瘤学组织，ASTRO致力于通过专业的教育和培训，支持临床实践和卫生政策标准，促进科学研究和宣传等，改善对患者的护理。
泌尿肿瘤学会(SUO)成立于1984年，宗旨是提供一个讨论有关恶性泌尿系统疾病问题的平台；促进泌尿科肿瘤学的研究和教学；向广泛的医学界人士传播泌尿科肿瘤学的原则；改善对恶性GU肿瘤患者的护理。 2022 Genitourinary Cancers Symposium ASCO
San Francisco, California, United States + Online
February 17 to February 19 March 2022
重要日期：
LATE AUGUST 2021
Abstract Submission Launches
OCTOBER 12, 2021 at 11:59 PM (EDT)
Abstract Submission Deadline
DECEMBER 2021
Abstract Notifications Sent to First Authors by Email
DECEMBER 14, 2021 at 12:00 PM NOON (EST)
Late-Breaking Data Submission Deadline (instructions will be provided to first authors via email)
JANUARY 6, 2022 at 12:00 PM (EST)
Abstract Withdrawal Deadline (withdrawal requests must be emailed by first authors only)
EARLY JANUARY 2022
Abstract Titles Available on Meeting Library
JANUARY 12, 2022 at 11:59 PM (EST)
Early Registration Deadline
FEBRUARY 11, 2022 at 11:59 PM (EST)
Registration Cancellation Deadline
FEBRUARY 14, 2022 at 5:00 PM (EST)
Abstracts are Released on Meeting Library
FEBRUARY 17-19, 2022
Genitourinary Cancers Symposium
San Francisco, CA
Submission Fee/提交费: A $60 (USD) nonrefundable submission fee will be charged per abstract submitted. Payment is due at the time of submission.
摘要提交指南>>>Submission Guidelines & Requirements>>>
注册费-Registration Fees - In Person + Online
会员
| Registration Fees |
UNTIL JANUARY 12, 2022 |
Between January 13 - February 4, 2022 at 11:59 PM (ET) |
Beginning February 5, 2022 |
| Physician/Scientist Member | $540.00 | $660.00 | $760.00 |
| Early Career, Retired, and Emeritus Member | $275.00 | $395.00 | $495.00 |
| Physician/Scientist in Developing Countries Member | $195.00 | $315.00 | $415.00 |
| In-Training Member | $120.00 | $240.00 | $340.00 |
| Affiliated Health Professional Member | $275.00 | $395.00 | $495.00 |
| Patient Advocate Member | $0.00 | $0.00 | $0.00 |
非会员
| Registration Fees |
UNTIL JANUARY 12, 2022 |
Between January 13 - February 4, 2022 at 11:59 PM (ET) |
Beginning February 5, 2022 |
| Physician/Scientist Nonmember | $895.00 | $1015.00 | $1115.00 |
| Nonmedical or Industry Nonmember | $1030.00 | $1150.00 | $1250.00 |
| In-Training Nonmember* | $180.00 | $300.00 | $400.00 |
| Affiliated Health Professional Nonmember* | $450.00 | $570.00 | $670.00 |
| Patient Advocate Nonmember* | $0.00 | $0.00 | $0.00 |
*Special Rate Categories (Additional information required from nonmembers to verify attendee eligibility for these categories)
The registration fee for online-only attendees includes:
- Access to live stream of most meeting sessions as well as online posters and online exhibitor directory
- On demand access to session content (videos and slides), available approximately 6-12 hours after the live session
- Ability to download presentation slides and posters
- Access to online meeting materials including the Genitourinary Cancers Symposium program and Abstracts
- Continuing Medical Education (CME) credits and Maintenance of Certification (MOC) points from the ABIM for physicians
会议对象: 医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
免责条款：本站信息均收集整理自互联网，访问者如需了解更多详情，请进入相关活动官网，本站不对相关信息的准确性承担任何责任； 若本站的资讯侵害您的权益，请发送邮件到[email protected]，本站将在核实相关情况后第一时间删除。继续访问本站视为认同以上条款。
更多会议活动:
2022年第7届国际头颈肿瘤学会联盟世界大会(IFHNOS 2022)
2021年第9届欧洲头颈肿瘤学大会（ECHNO）
2022年欧洲肿瘤内科学会亚洲年会(ESMO ASIA 2022)
2022年ESMO俄罗斯峰会-ESMO SUMMIT RUSSIA 2022
2021年西方妇科肿瘤医师协会(WAGO)年会
2021年第7届亚太肿瘤介入大会(APCIO)
2023年第7届ESO-ESMO晚期乳腺癌国际共识大会(ABC7)
2023年第8届亚洲头颈部肿瘤学会大会
2022年第19届癌症免疫治疗协会年会
2022年第4届国际头颈癌HPV感染研讨会
